Health
Second study testing a COVID-19 antibody drug reports setback – 8News
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalized patients.
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalized patients.
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need intense oxygen treatment or breathing machines — because of a potential safety problem and unfavorable balance of risks and benefits.
The study can continue to test the two-antibody…
-
Business22 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
General21 hours agoFederal government funding extends cohealth GP services until July 2026
-
General5 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Noosa News19 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region